A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients

This trial is testing the safety and effectiveness of an experimental drug called SSGJ-707 in women with advanced endometrial cancer or platinum-resistant ovarian cancer. **You may be eligible if...** - You are between 18 and 75 years old - You have advanced endometrial cancer, OR ovarian cancer that has stopped responding to platinum-based chemotherapy - You are in good general health (ECOG 0 or 1) - Your expected survival is at least 12 weeks - You have signed informed consent **You may NOT be eligible if...** - You have active or uncontrolled brain metastases - You have unresolved side effects (grade 2 or higher) from prior cancer treatment (except hair loss or fatigue) - Your organ or bone marrow function is not adequate - You are pregnant or breastfeeding - You have a known allergy or intolerance to SSGJ-707 Talk to your doctor to see if this trial is right for you.